Ji Yih Chen1, Yee Ling Wu2, Mo Yin Mok3, Yeong-Jian Jan Wu1, Katherine E Lintner2, Chin-Man Wang4, Erwin K Chung2, Yan Yang2, Bi Zhou2, Huanyu Wang2, Dennis Yu2, Alaaedin Alhomosh2, Karla Jones2, Charles H Spencer2, Haikady N Nagaraja5, Yu Lung Lau6, Chak-Sing Lau3, C Yung Yu2. 1. Department of Medicine, Division of Allergy, Immunology and Rheumatology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taiwan, Republic of China. 2. Center for Molecular and Human Genetics, The Research Institute and Division of Pediatric Rheumatology, Nationwide Children's Hospital; and Department of Pediatrics, The Ohio State University, 700 Children's Drive, Columbus, Ohio 43205, USA. 3. Division of Rheumatology, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China. 4. Department of Rehabilitation, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taiwan, Republic of China. 5. Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, Ohio 43201, USA. 6. Department of Pediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Abstract
OBJECTIVE: Human complement C4 is complex, with multiple layers of diversity. The aims of this study were to elucidate the copy number variations (CNVs) of C4A and C4B in relation to disease risk in systemic lupus erythematosus (SLE), and to compare the basis of race-specific C4A deficiency between East Asians and individuals of European descent. METHODS: The East Asian study population included 999 SLE patients and 1,347 healthy subjects. Variations in gene copy numbers (GCNs) of total C4, C4A, and C4B, as well as C4-Long and C4-Short genes, were determined and validated using independent genotyping technologies. Genomic regions with C4B96 were investigated to determine the basis of the most basic C4B protein occurring concurrently with C4A deficiency. RESULTS: In East Asians, high GCNs of total C4 and C4A were strongly protective against SLE, whereas low and medium GCNs of total C4 and C4A, and the absence of C4-Short genes, were risk factors for SLE. Homozygous C4A deficiency was infrequent in East Asian subjects, but had an odds ratio (OR) of 12.4 (P = 0.0015) for SLE disease susceptibility. Low serum complement levels were strongly associated with low GCNs of total C4 (OR 3.19, P = 7.3 × 10(-7) ) and C4B (OR 2.53, P = 2.5 × 10(-5) ). Patients with low serum complement levels had high frequencies of anti-double-stranded DNA antibodies (OR 4.96, P = 9.7 × 10(-17) ), hemolytic anemia (OR 3.89, P = 3.6 × 10(-10) ), and renal disease (OR 2.18, P = 8.5 × 10(-6) ). The monomodular-Short haplotype found to be prevalent in European Americans with C4A deficiency, which was in linkage disequilibrium with HLA-DRB1*0301, was scarce in East Asians. Instead, most East Asian subjects with C4A deficiency were found to have a recombinant haplotype with bimodular C4-Long and C4-Short genes, encoding C4B1 and C4B96, which was linked to HLA-DRB1*1501. DNA sequencing revealed an E920K polymorphism in C4B96. CONCLUSION: C4 CNVs and deficiency of C4A both play an important role in the risk and manifestations of SLE in East Asian and European populations.
OBJECTIVE:Human complement C4 is complex, with multiple layers of diversity. The aims of this study were to elucidate the copy number variations (CNVs) of C4A and C4B in relation to disease risk in systemic lupus erythematosus (SLE), and to compare the basis of race-specific C4A deficiency between East Asians and individuals of European descent. METHODS: The East Asian study population included 999 SLEpatients and 1,347 healthy subjects. Variations in gene copy numbers (GCNs) of total C4, C4A, and C4B, as well as C4-Long and C4-Short genes, were determined and validated using independent genotyping technologies. Genomic regions with C4B96 were investigated to determine the basis of the most basic C4B protein occurring concurrently with C4A deficiency. RESULTS: In East Asians, high GCNs of total C4 and C4A were strongly protective against SLE, whereas low and medium GCNs of total C4 and C4A, and the absence of C4-Short genes, were risk factors for SLE. Homozygous C4A deficiency was infrequent in East Asian subjects, but had an odds ratio (OR) of 12.4 (P = 0.0015) for SLE disease susceptibility. Low serum complement levels were strongly associated with low GCNs of total C4 (OR 3.19, P = 7.3 × 10(-7) ) and C4B (OR 2.53, P = 2.5 × 10(-5) ). Patients with low serum complement levels had high frequencies of anti-double-stranded DNA antibodies (OR 4.96, P = 9.7 × 10(-17) ), hemolytic anemia (OR 3.89, P = 3.6 × 10(-10) ), and renal disease (OR 2.18, P = 8.5 × 10(-6) ). The monomodular-Short haplotype found to be prevalent in European Americans with C4A deficiency, which was in linkage disequilibrium with HLA-DRB1*0301, was scarce in East Asians. Instead, most East Asian subjects with C4A deficiency were found to have a recombinant haplotype with bimodular C4-Long and C4-Short genes, encoding C4B1 and C4B96, which was linked to HLA-DRB1*1501. DNA sequencing revealed an E920K polymorphism in C4B96. CONCLUSION:C4 CNVs and deficiency of C4A both play an important role in the risk and manifestations of SLE in East Asian and European populations.
Authors: Yee Ling Wu; Stephanie L Savelli; Yan Yang; Bi Zhou; Brad H Rovin; Daniel J Birmingham; Haikady N Nagaraja; Lee A Hebert; C Yung Yu Journal: J Immunol Date: 2007-09-01 Impact factor: 5.422
Authors: Lora Boteva; David L Morris; Josefina Cortés-Hernández; Javier Martin; Timothy J Vyse; Michelle M A Fernando Journal: Am J Hum Genet Date: 2012-03-01 Impact factor: 11.025
Authors: Jennie G Pouget; Buhm Han; Yang Wu; Emmanuel Mignot; Hanna M Ollila; Jonathan Barker; Sarah Spain; Nick Dand; Richard Trembath; Javier Martin; Maureen D Mayes; Lara Bossini-Castillo; Elena López-Isac; Ying Jin; Stephanie A Santorico; Richard A Spritz; Hakon Hakonarson; Constantin Polychronakos; Soumya Raychaudhuri; Jo Knight Journal: Hum Mol Genet Date: 2019-10-15 Impact factor: 6.150
Authors: Max Lam; Chia-Yen Chen; Zhiqiang Li; Alicia R Martin; Julien Bryois; Xixian Ma; Helena Gaspar; Masashi Ikeda; Beben Benyamin; Brielin C Brown; Ruize Liu; Wei Zhou; Lili Guan; Yoichiro Kamatani; Sung-Wan Kim; Michiaki Kubo; Agung A A A Kusumawardhani; Chih-Min Liu; Hong Ma; Sathish Periyasamy; Atsushi Takahashi; Zhida Xu; Hao Yu; Feng Zhu; Wei J Chen; Stephen Faraone; Stephen J Glatt; Lin He; Steven E Hyman; Hai-Gwo Hwu; Steven A McCarroll; Benjamin M Neale; Pamela Sklar; Dieter B Wildenauer; Xin Yu; Dai Zhang; Bryan J Mowry; Jimmy Lee; Peter Holmans; Shuhua Xu; Patrick F Sullivan; Stephan Ripke; Michael C O'Donovan; Mark J Daly; Shengying Qin; Pak Sham; Nakao Iwata; Kyung S Hong; Sibylle G Schwab; Weihua Yue; Ming Tsuang; Jianjun Liu; Xiancang Ma; René S Kahn; Yongyong Shi; Hailiang Huang Journal: Nat Genet Date: 2019-11-18 Impact factor: 38.330
Authors: Katherine E Lintner; Yee Ling Wu; Yan Yang; Charles H Spencer; Georges Hauptmann; Lee A Hebert; John P Atkinson; C Yung Yu Journal: Front Immunol Date: 2016-02-15 Impact factor: 7.561
Authors: Léa Simoni; Jessy Presumey; Cees E van der Poel; Carlos Castrillon; Sarah E Chang; Paul J Utz; Michael C Carroll Journal: Cell Rep Date: 2020-11-03 Impact factor: 9.423